ARMISTICE CAPITAL, LLC

Q1 2025 13F-HR Holdings

Location
New York, NY
Holdings as of
3/31/2025
Date filed
5/15/2025
Form type
13F-HR
Num holdings
225
Total value ($000)
$6,672,407
Net value change ($000)
-657,579 (-9.0%)
New positions
64
Sold out positions
59
Turnover %
23.4%
Sector allocation + QoQ delta (equities-only)
Prev filing: 2/14/2025 Next filing: 8/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q4 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
FRPT 59,630 NEW
REGN 52,372 262.2%
SNN 38,044 313.3%
KDP 37,632 NEW
STAA 31,709 149.7%
TVTX 30,810 24.0%
MRK 29,086 NEW
AVNS 28,660 NEW
DPZ 20,452 97.7%
HELE 19,845 NEW
Top Reduces (Value $000, Stocks/ETFs)
Inari Medical, Inc. -79,923 -100.0%
ICLR -70,174 -80.0%
BUD -68,045 -100.0%
VRTX -65,970 -73.1%
GSK -65,780 -81.8%
HUM -64,334 -81.3%
NVO -53,746 -87.8%
SNY -31,130 -51.7%
MNST -29,929 -100.0%
SBUX -29,211 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 2,930,352 (43.9% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type